Biospecimen Processing Team

Organization profile

  • Highly standardised and automated processing of biospecimens from continuous routine and static clinical collections  
  • Highly standardised and automated transformation and derivation of biospecimens   
  • Highly specialised processing and characterisation e.g. 16S Sequencing,  Elispot and ddPCR   
  • All operations performed under fully traceable Laboratory Information Management System (LIMS)  

Fingerprint

Dive into the research topics where Biospecimen Processing Team is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
View full fingerprint

Network

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Explore network further
View all 4 profiles

  • Age at onset as stratifier in idiopathic Parkinson’s disease – effect of ageing and polygenic risk score on clinical phenotypes

    Pavelka, L., Rauschenberger, A., Landoulsi, Z., Pachchek, S., May, P., Glaab, E., Krüger, R., Acharya, G., Aguayo, G., Alexandre, M., Ali, M., Allen, D., Ammerlann, W., Balling, R., Bassis, M., Beaumont, K., Becker, R., Bellora, C., Berchem, G., Berg, D., & 31 othersBisdorff, A., Brockmann, K., Calmes, J., Castillo, L., Contesotto, G., Diederich, N., Dondelinger, R., Esteves, D., Fagherazzi, G., Ferrand, J. Y., Gantenbein, M., Gasser, T., Gawron, P., Ghosh, S., Glaab, E., Gomes, C., De Lope, E. G., Hanff, A. M., Hansen, M., Krüger, R., Lambert, P., Mittelbronn, M., Mommaerts, K., Nehrbass, U., Nickels, S., Pauly, L., Perquin, M., Sandt, E., Sokolowska, K., Vaillant, M. & on behalf of the NCER-PD Consortium, 9 Aug 2022, In: npj Parkinson's Disease. 8, 1, 102.

    Research output: Contribution to journal › Article › Research › peer-review

    Open Access

  • Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    Abani, O., Abbas, A., Abbas, F., Abbas, M., Abbasi, S., Abbass, H., Abbott, A., Abdallah, N., Abdelaziz, A., Abdelfattah, M., Abdelqader, B., Abdul, B., Abdul Rasheed, A., Abdulakeem, A., Abdul-Kadir, R., Abdullah, A., Abdulmumeen, A., Abdul-Raheem, R., Abdulshukkoor, N., Abdusamad, K., & 33 othersAbed El Khaleq, Y., Abedalla, M., Abeer Ul Amna, A. U. A., Abernethy, K., Aboaba, A., Abo-Leyah, H., Abou-Haggar, A., Abouibrahim, M., Abraham, M., Abraham, T., Abraheem, A., Abrams, J., Abu, H. J., Abu-Arafeh, A., Abubacker, S. M., Abung, A., Aceampong, Y., Achara, A., Acharya, D., Acheampong, S., Acheson, J., Acosta, A., Acton, C., Adabie-Ankrah, J., Adam, F., Adam, M., Adamali, H., Adams, C., Adams, C., RECOVERY Collaborative Group, Lambert, P., Horby, P. W. & Landray, M. J., 8 Jan 2022, In: The Lancet. 399, 10320, p. 143-151 9 p.

    Research output: Contribution to journal › Article › Research › peer-review

    Open Access
    95 Citations (Scopus)

  • Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    Abani, O., Abbas, A., Abbas, F., Abbas, M., Abbasi, S., Abbass, H., Abbott, A., Abdallah, N., Abdelaziz, A., Abdelfattah, M., Abdelqader, B., Abdul, B., Abdul Rasheed, A., Abdulakeem, A., Abdul-Kadir, R., Abdullah, A., Abdulmumeen, A., Abdul-Raheem, R., Abdulshukkoor, N., Abdusamad, K., & 33 othersAbed El Khaleq, Y., Abedalla, M., Ul-Amna, A., Abernethy, K., Aboaba, A., Abo-Leyah, H., Abou-Haggar, A., Abouibrahim, M., Abraham, M., Abraham, T., Abraheem, A., Abrams, J., Abu, H. J., Abu-Arafeh, A., Abubacker, S. M., Abung, A., Aceampong, Y., Achara, A., Acharya, D., Acheampong, S., Acheson, J., Acosta, A., Acton, C., Adabie-Ankrah, J., Adam, F., Adam, M., Adamali, H., Adams, C., Adams, C., Lambert, P., Horby, P. W., RECOVERY Collaborative Group & Landray, M. J., 12 Feb 2022, In: The Lancet. 399, 10325, p. 665-676 12 p.

    Research output: Contribution to journal › Article › Research › peer-review

    Open Access
    99 Citations (Scopus)
View all 17 research outputs